Company intelligence / Profile preview
Zytras Life Sciences
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
Overview
Zytras Life Sciences manufactures and markets a range of pharmaceutical products in India. The company offers both generic medicines and specialty drugs across multiple therapeutic areas. Products include antibiotics like cefpodoxime proxetil ("Zypod"), vitamin supplements like thiamine ("Nervion"), gastroenterological products ("Rabgit DSR Capsule"), among others. There are no clinical trial results or novel drug development programs reported; the business model centers on manufacturing quality-assured medicines for distribution through franchise/PCD channels.
- Therapeutic areas
- OtherMetabolic DisordersInfectious Diseases
- Modalities
- Small molecules (oral solid dosage forms such as tablets and capsules)
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Zytras Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zytras Life Sciences.